metiamide and Hepatic-Encephalopathy

metiamide has been researched along with Hepatic-Encephalopathy* in 1 studies

Trials

1 trial(s) available for metiamide and Hepatic-Encephalopathy

ArticleYear
H2-receptor antagonists and antacids in the prevention of acute gastrointestinal haemorrhage in fulminant hepatic failure. Two controlled trials.
    Lancet (London, England), 1977, Mar-19, Volume: 1, Issue:8012

    In two controlled trials, involving 75 patients, on the prevention of bleeding from gastric erosions in fulminant hepatic failure, antacids given four-hourly had no significant effect. Only 35% of intragastric pH recordings taken at two-hourly intervals in the treated group were maintained above 5 with the doses used, whereas this could be consistently achieved with the histamine H2-receptor antagonists, metiamide and cimetidine. In the group receiving these drugs only 1 patient out of 26 bled, compared with 13 (54%) of the controls, a highly significant difference. Blood-transfusion requirements were significantly less in those treated with H2-receptor antagonists.

    Topics: Antacids; Clinical Trials as Topic; Drug Evaluation; Esophageal and Gastric Varices; Gastrointestinal Hemorrhage; Guanidines; Hepatic Encephalopathy; Histamine H2 Antagonists; Humans; Imidazoles; Metiamide; Peptic Ulcer Hemorrhage; Stomach Ulcer

1977